Ibuprofen

布洛芬

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameIbuprofen
Drug Alias Name异丁苯丙酸Ibuprofeno异丁洛芬IbuprofenumAktren +[27] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPostoperative inflammationCognitive DysfunctionCognition Disorders +[52] 
Global Approved IndicationsPainDysmenorrheaOsteoarthritis +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1969/01/01
Country/TerritoryBelgiumBulgariaCanada +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesMcneil Consumer Pharmaceuticals CoCanadian Institutes Of Health Research (Cihr)Overseas Pharmaceuticals Ltd +[28] 
Inactive CompaniesChengdu University Of TcmPlx PharmaBrainfarma Industria Química E Farmacêutica S/A +[51] 
Active IndicationsCognition DisordersBipolar DisorderHeadache +[28] 
Inactive IndicationsPostoperative inflammationCognitive DysfunctionDepressive Disorder, Major +[24] 

Other Information

ATC CodeC01EB16G02CC01M01AE01 +[5] 
Related LinksWikipediaDrugBankKEGG